List of Tables
Table 1. Alzheimer’s Disease Diagnostic Market Trends
Table 2. Alzheimer’s Disease Diagnostic Market Drivers & Opportunity
Table 3. Alzheimer’s Disease Diagnostic Market Challenges
Table 4. Alzheimer’s Disease Diagnostic Market Restraints
Table 5. Global Alzheimer’s Disease Diagnostic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Alzheimer’s Disease Diagnostic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Alzheimer’s Disease Diagnostic Product Type
Table 9. Key Companies Time to Begin Mass Production of Alzheimer’s Disease Diagnostic
Table 10. Global Alzheimer’s Disease Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Alzheimer’s Disease Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Alzheimer’s Disease Diagnostic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Alzheimer’s Disease Diagnostic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Alzheimer’s Disease Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Alzheimer’s Disease Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Alzheimer’s Disease Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Alzheimer’s Disease Diagnostic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Alzheimer’s Disease Diagnostic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Alzheimer’s Disease Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Alzheimer’s Disease Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Alzheimer’s Disease Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Alzheimer’s Disease Diagnostic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Alzheimer’s Disease Diagnostic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Alzheimer’s Disease Diagnostic Sales Value by Region (2019-2024) & (%)
Table 27. Global Alzheimer’s Disease Diagnostic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Alzheimer’s Disease Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Alzheimer’s Disease Diagnostic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Alzheimer’s Disease Diagnostic Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly and Company Basic Information List
Table 32. Eli Lilly and Company Description and Business Overview
Table 33. Eli Lilly and Company Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Eli Lilly and Company (2019-2024)
Table 35. Eli Lilly and Company Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Novartis (2019-2024)
Table 40. Novartis Recent Developments
Table 41. Merck Basic Information List
Table 42. Merck Description and Business Overview
Table 43. Merck Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Merck (2019-2024)
Table 45. Merck Recent Developments
Table 46. F. Hoffmann-La Roche Basic Information List
Table 47. F. Hoffmann-La Roche Description and Business Overview
Table 48. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of F. Hoffmann-La Roche (2019-2024)
Table 50. F. Hoffmann-La Roche Recent Developments
Table 51. Pfizer Basic Information List
Table 52. Pfizer Description and Business Overview
Table 53. Pfizer Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Pfizer (2019-2024)
Table 55. Pfizer Recent Developments
Table 56. TauRx Basic Information List
Table 57. TauRx Description and Business Overview
Table 58. TauRx Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of TauRx (2019-2024)
Table 60. TauRx Recent Developments
Table 61. Alector Basic Information List
Table 62. Alector Description and Business Overview
Table 63. Alector Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Alector (2019-2024)
Table 65. Alector Recent Developments
Table 66. Accera Basic Information List
Table 67. Accera Description and Business Overview
Table 68. Accera Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Accera (2019-2024)
Table 70. Accera Recent Developments
Table 71. Treventis Corporation Basic Information List
Table 72. Treventis Corporation Description and Business Overview
Table 73. Treventis Corporation Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Treventis Corporation (2019-2024)
Table 75. Treventis Corporation Recent Developments
Table 76. Neuro-Bio Basic Information List
Table 77. Neuro-Bio Description and Business Overview
Table 78. Neuro-Bio Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Neuro-Bio (2019-2024)
Table 80. Neuro-Bio Recent Developments
Table 81. Cognition Therapeutics Basic Information List
Table 82. Cognition Therapeutics Description and Business Overview
Table 83. Cognition Therapeutics Alzheimer’s Disease Diagnostic Products, Services and Solutions
Table 84. Revenue (US$ Million) in Alzheimer’s Disease Diagnostic Business of Cognition Therapeutics (2019-2024)
Table 85. Cognition Therapeutics Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Alzheimer’s Disease Diagnostic Downstream Customers
Table 89. Alzheimer’s Disease Diagnostic Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Alzheimer’s Disease Diagnostic Product Picture
Figure 2. Global Alzheimer’s Disease Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 4. Alzheimer’s Disease Diagnostic Report Years Considered
Figure 5. Global Alzheimer’s Disease Diagnostic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Alzheimer’s Disease Diagnostic Revenue in 2023
Figure 7. Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Nervous System Examination Picture
Figure 9. Genetic Testing Picture
Figure 10. Minor Mental State Examination (Mmse) Picture
Figure 11. Brain Imaging Picture
Figure 12. Global Alzheimer’s Disease Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Alzheimer’s Disease Diagnostic Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Early-Onset Alzheimer's Disease
Figure 15. Product Picture of Familial Alzheimer's Disease
Figure 16. Product Picture of Late-Onset Alzheimer's Disease
Figure 17. Global Alzheimer’s Disease Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Alzheimer’s Disease Diagnostic Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Alzheimer’s Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Alzheimer’s Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Alzheimer’s Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Alzheimer’s Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Alzheimer’s Disease Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Alzheimer’s Disease Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Alzheimer’s Disease Diagnostic Sales Value (%), (2019-2030)
Figure 30. United States Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 36. China Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 38. China Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 48. India Alzheimer’s Disease Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Alzheimer’s Disease Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 50. India Alzheimer’s Disease Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 51. Alzheimer’s Disease Diagnostic Industrial Chain
Figure 52. Alzheimer’s Disease Diagnostic Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
